RA
STLN

Ramius Advisors’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Ramius Advisors’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65,724
Closed -$655K – 301
2021
Q1 		$655K Buy
+65,724
New +$700K 0.17% 142

Other funds holding STLN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Ramius Advisors's STLN Position: Q2 2021 in Review

Ramius Advisors sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2021, closing a stake of 65,724 shares — an estimated $655K sold.

Ramius Advisors first reported a position in STLN in Q1 2021 and held it in 1 quarter. The position peaked at $655K in Q1 2021. 53 funds tracked by Wall St. Rank hold STLN as of Q2 2021.

  • Ramius Advisors reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ramius Advisors sold 65,724 Starling Oncology Institute, Inc. Common Stock shares in Q2 2021, an estimated $655K.
  • Ramius Advisors first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Ramius Advisors's Starling Oncology Institute, Inc. Common Stock position peaked at $655K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2021.

Based on Ramius Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.